Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > 3D Biosensor Platform by Silicon Kinetics Receives Most Innovative Product (MIP) Award from CONNECT

Abstract:
SKi Pro™ 3D biomolecular interaction analysis platform by Silicon Kinetics Inc., a privately-held life sciences tool company, has been recognized as the Most Innovative Product in the "Diagnostics and Research Tools" category in the 21st Annual Most Innovative New Product (MIP) Awards by CONNECT, a non-profit organization dedicated to creating and sustaining the growth of innovative technology and life science businesses in San Diego.

3D Biosensor Platform by Silicon Kinetics Receives Most Innovative Product (MIP) Award from CONNECT

San Diego, CA | Posted on December 18th, 2008

SKi Pro™ 3D biomolecular interaction analysis platform by Silicon Kinetics Inc., a privately-held life sciences tool company, has been recognized as the Most Innovative Product in the "Diagnostics and Research Tools" category in the 21st Annual Most Innovative New Product (MIP) Awards by CONNECT, a non-profit organization dedicated to creating and sustaining the growth of innovative technology and life science businesses in San Diego.

Silicon Kinetics SKi Pro is the world's first 3D label-free platform for biomolecular interaction analysis in proteomics research, biomarker and drug discovery, vaccine development as well as quality control in drug manufacturing. With SKi Pro, a precision optical reader for a unique 3D nano-porous silicon biosensor surface, Silicon Kinetics has introduced the most sensitive and the most flexible, low- or high-throughput analytical platform for studying interactions such as protein-protein, DNA-protein, protein-small molecule.

CONNECT's MIP program subjects the nominees to a rigorous selection process, including review by a committee of industry experts, and a panel of judges made up of San Diego's business, civic and academic leaders. Past winners in the Life Sciences sector included Invitrogen, Biosite, Gen-Probe, Pfizer, Amylin and IDEC Pharmaceuticals. The criteria include commercial sales of the Most Innovative Product.

"Recognition of SKi Pro 3D biomolecular interaction platform as the Most Innovative Product by CONNECT is a tribute to our scientists and engineers," said Hus Tigli, President & CEO of Silicon Kinetics. "The innovations in SKi Pro provide unprecedented benefits to researchers in pharmaceutical and biotech industries as well as research and academic institutions. These benefits include sensitivity, ease of use, and screen-then-characterize versatility on the same cost-effective instrument platform."

####

About Silicon Kinetics Inc.
Silicon Kinetics, Inc. is a privately-held life sciences tools company headquartered in San Diego, California. The Company specializes in instruments for optical interferometry in nano-porous silicon biochips. The SKi Pro™ instrument platform and the 3D SKi Sensor™ biochips are used to detect protein-protein, protein-drug, or protein-DNA interactions in real-time and quantify binding kinetics, dissociation rates, or biomolecular affinity rankings, required for the study of disease pathways and the development and manufacturing of therapeutics.

For more information, please click here

Contacts:
Ronald P. Dudek
Silicon Kinetics
(517) 294-7272


Cynthia Guiang
CG Communications
858-793-2471

Copyright © PRWeb™

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

New discovery aims to improve the design of microelectronic devices September 13th, 2024

Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024

Atomic force microscopy in 3D July 5th, 2024

Aston University researcher receives £1 million grant to revolutionize miniature optical devices May 17th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project